The Lancet Oncology 公開
[search 0]

Download the App!

show episodes
Loading …
show series
Manju Sengar (Tata Memorial Centre, India) and Christopher Booth (Queen’s University Cancer Research Institute, Canada) discuss their Article on the comparison between cancer drugs deemed essential by oncologists and those included in the WHO Essential Medicines List.The Lancet による
Series authors discuss the Global Cancer Control Networks Series on how high-income countries, particularly the UK and Canada, can help with cancer control in low-income and middle-income countries.The Lancet による
Hedvig Hricak (Memorial Sloan Kettering Cancer Center), Andrew Scott (Olivia Newton-John Cancer Research Institute), Rifat Atun (Harvard TH Chan School of Public Health), and May Abdel-Wahab (International Atomic Energy Agency) discuss The Lancet Oncology’s Commission on Medical Imaging and Nuclear Medicine.…
Lisa Bodei (Memorial Sloan Kettering Cancer Center, New York, NY, USA) discusses the Review in The Lancet Oncology on molecular profiling of neuroendocrine tumours to predict response to peptide receptor radionuclide therapy.The Lancet による
Rifat Atun (Harvard T H Chan School of Public Health, Harvard University, Boston, MA, USA) discusses a Review in The Lancet Oncology on global patterns in public and philanthropic funding for childhood cancer research with Senior Editor Márcia Costa.The Lancet による
Loading …


Google login Twitter login Classic login